ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

462
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
bullishFast Retailing
11 Feb 2018 09:36

Last Week in Event SPACE - Fast Retailing, Hyundai Heavy, Japan Display, Qualcomm, Intouch

Last week, Fast Retailing Co Ltd (9983 JP) may be materially impacted should the BOJ revamp its purchase programs; a decent arb return in Hyundai...

Logo
304 Views
Share
bullishCelltrion Inc
09 Feb 2018 06:22

KOSDAQ 150 Rebalancing & Celltrion Short Selling During Feb 7-8

The KRX officially said on Feb 7 that Celltrion Inc (068270 KS) would be listed on the KOSPI on Feb 9. This means there would be a massive index...

Logo
305 Views
Share
bullishCelltrion Inc
04 Feb 2018 00:10

Last Week in Event SPACE - Astellas, Celltrion, Renesas, AWE, Viva, Kushikatsu

Last week, Astellas Pharma Inc (4503 JP)'s latest buyback may impact the stock; KOSDAQ 150 names expected to benefit as Celltrion Inc (068270 KS)...

Logo
195 Views
Share
bullishCelltrion Inc
30 Jan 2018 20:45

Impact Analysis of Celltrion's KOSPI Move on KOSPI 200 and KOSDAQ 150

The KRX senior official named Lee Eun-tae had a press conference yesterday (Jan 29). He gave the major projects that the KRX is currently planning...

Logo
389 Views
Share
bullishCelltrion Inc
05 Jan 2018 12:28

Celltrion (068270 KS): Korean Making Biological Drugs for the West

Solid long-term sales growth, strong sales momentum, and high earnings quality relative to its sector Celltrion is one of Korea’s top exporters of...

Share
x